Simulator helps sponsors to assess arrhythmia risk before a candidate enters clinical trials; determine safe drug doses for specific patient populations ST. LOUIS, Aug 01, 2013 (BUSINESS WIRE) -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results